Industry and Diagnostic developers
Click 'find out more', below, for how to submit your diagnostic / kit for inclusion in CONDOR.
A single route to evaluate new diagnostic tests for COVID-19
CONDOR is accelerating how quickly promising COVID-19 diagnostics make it into real-world use. The platform is evaluating new COVID-19 diagnostics in the settings they will be used, such as in GP surgeries, care homes or hospitals, as well as their performance in laboratory settings.
These tests will be used to support diagnosis and management of patients with suspected COVID-19, and collect data to help develop effective diagnostic pathways for subsequent waves of infection in the post-pandemic setting.
The platform comprises a number of partners, including Manchester University NHS Foundation Trust's Diagnostic and Technology Accelerator (DiTA), and NIHR MedTech and In Vitro Diagnostics Co-operatives (MICs) based in Oxford, Leeds, London and Newcastle.
CONDOR is funded by UK Research and Innovation, the Department of Health and Social Care through the National Institute for Health Research, Asthma UK and the British Lung Foundation.
CONDOR Activity Report
View a 'by the numbers' update of CONDOR's progress, including the number of test sites, participants and types of point-of-care diagnostics tested.
Last updated: 10 June 2021